Trial Profile
A single centre phase II study of Interleukin 1 receptor antagonist in the treatment of severe Traumatic Brain Injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2019
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Traumatic stress disorders
- Focus Adverse reactions
- 17 Sep 2015 New trial record